Regenxbio Inc (RGNX)
19.31
-0.25 (-1.28%)
USD |
NASDAQ |
May 24, 15:20
Regenxbio Price: 19.31 for May 24, 2022
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 23, 2022 | 20.30 | 20.74 | 19.38 | 19.56 | 356021.0 |
| May 20, 2022 | 19.95 | 20.23 | 18.99 | 20.08 | 272947.0 |
| May 19, 2022 | 19.56 | 19.90 | 18.69 | 19.65 | 440228.0 |
| May 18, 2022 | 21.70 | 21.70 | 19.21 | 19.57 | 501554.0 |
| May 17, 2022 | 21.25 | 21.76 | 20.83 | 21.70 | 356752.0 |
| May 16, 2022 | 20.63 | 21.37 | 20.12 | 20.67 | 415868.0 |
| May 13, 2022 | 20.26 | 21.41 | 20.26 | 20.84 | 443782.0 |
| May 12, 2022 | 19.07 | 20.50 | 19.07 | 19.79 | 647132.0 |
| May 11, 2022 | 20.97 | 21.34 | 19.18 | 19.48 | 608197.0 |
| May 10, 2022 | 21.11 | 22.38 | 20.49 | 21.14 | 475706.0 |
| May 09, 2022 | 22.28 | 22.31 | 19.87 | 20.01 | 512926.0 |
| May 06, 2022 | 24.41 | 24.41 | 22.03 | 22.23 | 454730.0 |
| May 05, 2022 | 27.21 | 27.94 | 23.66 | 24.20 | 805859.0 |
| May 04, 2022 | 28.45 | 28.66 | 26.73 | 28.44 | 346410.0 |
| May 03, 2022 | 28.36 | 28.78 | 27.83 | 28.22 | 224089.0 |
| May 02, 2022 | 27.65 | 28.58 | 27.33 | 28.44 | 455195.0 |
| Apr 29, 2022 | 28.37 | 29.07 | 27.64 | 27.76 | 364661.0 |
| Apr 28, 2022 | 28.62 | 28.68 | 26.92 | 28.54 | 368085.0 |
| Apr 27, 2022 | 28.06 | 28.96 | 27.59 | 28.01 | 441757.0 |
| Apr 26, 2022 | 29.20 | 29.68 | 27.94 | 28.11 | 510501.0 |
| Apr 25, 2022 | 29.43 | 29.98 | 29.18 | 29.36 | 309418.0 |
| Apr 22, 2022 | 29.49 | 30.43 | 29.08 | 29.53 | 265090.0 |
| Apr 21, 2022 | 31.21 | 31.91 | 29.74 | 29.76 | 322219.0 |
| Apr 20, 2022 | 29.91 | 31.29 | 29.91 | 30.94 | 385930.0 |
| Apr 19, 2022 | 29.62 | 30.88 | 28.86 | 30.22 | 291845.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
16.70
Minimum
May 30 2017
82.15
Maximum
Jul 10 2018
39.29
Average
36.80
Median
Price Benchmarks
| AbbVie Inc | 148.71 |
| Passage Bio Inc | 1.75 |
| Corcept Therapeutics Inc | 19.99 |
| Cytokinetics Inc | 38.55 |
| MannKind Corp | 4.00 |
Price Related Metrics
| PE Ratio | 8.981 |
| PS Ratio | 1.801 |
| Price to Book Value | 1.208 |
| Price to Free Cash Flow | 5.972 |
| Earnings Yield | 11.13% |
| Market Cap | 832.92M |
| Operating PE Ratio | 6.440 |
| Normalized PE Ratio | 9.723 |